NurExone CEO to speak at Exosome — Based Therapeutics Development Summit
NurExone will attend four Boston life sciences conferences from Sept. 22-25, 2026 to market its exosome-therapy programs. CEO Dr. Lior Shaltiel is scheduled to speak at the Exosome-Based Therapeutics Development Summit on Sept. 22-24. Shaltiel will also join an LSX Congress USA panel on Sept. 23. * BioProcess Internati